|
|||||
|
|
Vitamin D3-24-hydroxylase (CYP24) as a potential target for intervention with diabetic and nondiabetic nephropathy |
|
| Authors: | Weiher Hans Zwacka Ralf M |
| Affiliation: | GTX Pharmaceuticals, Gri?benzell, Germany. hans.weiher@fh-bonn-rhein-sieg.de |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |